Loading chart…
PRE-MARKET
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology.
Thyrocare Technologies Limited (THYROCARE) is listed on the NSE in the Healthcare sector, Diagnostics & Research industry. The THYROCARE share price is ₹498.95 (+0.90% today), with a market capitalisation of ₹79B and a price-to-earnings (P/E) ratio of 55.6. MarketRipple tracks the THYROCARE investment thesis, the ripple-chain impact of market events on Thyrocare Technologies Limited, and the Healthcare sector outlook.
Open
₹500.00
High
₹503.95
Low
₹493.10
Prev. Close
₹494.50
52W High
₹662.00
52W Low
₹342.55
Day range
₹493.10–₹503.95
52-week range
₹342.55–₹662.00
Volume
56K
P/E
55.6
ROE
26.4%
D/E
0.09
Margin
15.5%
Thyrocare Technologies Limited (NSE: THYROCARE) is currently trading at ₹498.95 (+0.90%).
Thyrocare Technologies Limited's market capitalization is ₹79B.
Thyrocare Technologies Limited's price-to-earnings (P/E) ratio is 55.6.
Thyrocare Technologies Limited operates in the Healthcare sector (Diagnostics & Research).
Analyst consensus on Thyrocare Technologies Limited currently reads strongly positive, based on 5 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.